Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2873 of 6351
-
Wearable device could monitor brain shunt function from home
Knowledge-focused Recruiting nowThis study evaluates the performance of a device for non-invasively assessing cerebrospinal fluid (CSF) shunt flow over multiple measurements performed by a study subject during activities of daily living and sleep
Sponsor: Rhaeos, Inc. • Aim: Knowledge-focused
Last updated Aug 27, 2026 00:00 UTC
-
Fiber fix for asthma? new study tests gut health link
Disease control Recruiting nowRandomized controlled trial of soluble fiber (Fruitafit Inulin). Participants will complete an ASA 24 dietary recall questionnaire to access their fiber intake. If eligible for the study, participants will be supplemented to their target fiber dosage with either soluble fiber (Fr…
Phase 2 • Sponsor: Phoenix Children's Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New PAH drug shows promise in Long-Term safety study
Disease control OngoingThe purpose of this study is to learn about the long-term safety, tolerability and effects of the study medicine (PF-07868489) for the possible treatment of PAH. PAH is a condition in which there is high blood pressure in the arteries that carry blood from the heart to the lungs.…
Phase 2 • Sponsor: Pfizer • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
New eczema drug shows promise in early trial
Disease control OngoingThe main purpose of this Ph2a study is to evaluate the preliminary efficacy, safety and tolerability of GIA632 when administered to adult participants with moderate to severe atopic dermatitis (AD).
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New drug combo may shield liver during cancer surgery
Disease control Recruiting nowA multicenter, open-label, randomized, controlled study. It is proposed to evaluate the treatment plan of receiving 930mg polyene phosphatidylcholine injection one day before the operation, twice a day, and 930mg polyene phosphatidylcholine injection twice a day,combined with 100…
Phase 4 • Sponsor: Anhui Provincial Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Electric current may boost Methotrexate's power against vitiligo
Disease control Not yet recruitingVitiligo is a common autoimmune depigmenting disorder characterized by selective destruction of melanocytes. Methotrexate (MTX) has shown potential in stabilizing disease activity and promoting repigmentation; however, systemic administration may cause hepatotoxicity. This pilot …
Sponsor: Pharos University in Alexandria • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Can weight loss surgery boost your brainpower? new study investigates
Knowledge-focused Recruiting nowThe goal of the study to understand the effects of weight loss and improvements in diabetes following bariatric surgery on brain function and thinking. This study will also examine whether non-invasive transcutaneous vagal nerve stimulation (tVNS) intervention initiated 30 days p…
Sponsor: University of Florida • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
Simple smell and taste exercises may bring flavor back to cancer patients' meals
Symptom relief Recruiting nowA multicentre non-blinded randomised intervention trial with a parallel cluster design. The multicentre study will be performed at 12 hospitals in the Netherlands. A parallel cluster design per hospital was selected to prevent contact between participants in the same hospital who…
Sponsor: University Medical Center Groningen • Aim: Symptom relief
Last updated Jul 17, 2026 00:00 UTC
-
Lifestyle program aims to cut colon cancer risk in high-risk individuals
Prevention Recruiting nowBackground Colorectal cancer is a significant health concern. For individuals identified as being at high risk for developing this disease, adopting healthy lifestyle behaviors is a powerful way to lower that risk. However, starting and maintaining these new habits can be challen…
Sponsor: China Medical University, China • Aim: Prevention
Last updated Jun 27, 2026 08:01 UTC
-
Gentler workout with blood flow cuffs may beat heavy lifting for back pain
Symptom relief Completedhis randomized clinical trial aims to compare the effects of low-load blood flow restriction (LL-BFR) training and traditional heavy-load resistance training (HL-RT) on male athletes with sub-acute non-specific low back pain. Participants will be randomly assigned to either the L…
Sponsor: University of Lahore • Aim: Symptom relief
Last updated Jun 27, 2026 11:04 UTC
-
New drug ANXV shows promise for common eye diseases in early trial
Disease control Recruiting nowThe goal of this clinical trial is to learn about the safety of the investigational medicinal product ANXV. It will also learn about how ANXV works to treat non-proliferative diabetic retinopathy and retinal vein occlusion in adults. The main questions it aims to answer are: * I…
Phase 2 • Sponsor: Annexin Pharmaceuticals AB • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New drug STRO-004 takes on advanced cancers in early trial
Disease control Recruiting nowThis is a study to evaluate the safety and preliminary anti-tumor activity of STRO-004 in adults with metastatic cancer. This study includes 3 parts: * Part 1A is a dose escalation study of STRO-004 monotherapy in selected tumor types known to commonly express Tissue Factor (TF)…
Phase 1 • Sponsor: Sutro Biopharma, Inc. • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
New drug targets cancer enzyme in early human trial
Disease control Recruiting nowThis phase I trial tests the safety, side effects, and best dose of MTI-301 in treating patients with solid cancers that have spread from where they first started (primary site) to other places in the body (metastatic) or that cannot be removed by surgery (unresectable) and that …
Phase 1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Nerve stimulation boosts hand therapy in infants with brain injury?
Symptom relief Recruiting nowPreterm and term infants with brain injury frequently have delayed motor skills, and one hand and arm may become stronger than the other, which can signal early cerebral palsy. A new treatment, transcutaneous vagus nerve stimulation (taVNS), boosts specific brain circuits and may…
Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
Could a High-Tech headband clear the fog of chemo brain?
Symptom relief Stopped earlyThe purpose of this study is to assess the feasibility of a wearing semiconductor embedded headband for cancer-related cognitive impairment in patients with breast or gynecological cancers. The study will also test the safety and effectiveness of using a semiconductor embedded he…
Phase 2 • Sponsor: University of Utah • Aim: Symptom relief
Last updated Aug 19, 2026 00:00 UTC
-
New stimulation pattern could ease tough back pain
Symptom relief Recruiting nowStudy to evaluate the effectiveness of time variant pulse (TVP)-SCS in patients with chronic pain using commercially approved Boston Scientific SCS Systems per local Instructions for use (IFU). In addition, to compile real-world clinical outcomes in subjects with chronic, intrac…
Sponsor: Boston Scientific Corporation • Aim: Symptom relief
Last updated Sep 05, 2026 00:00 UTC
-
New scan could sharply improve head & neck cancer surgery
Diagnosis Recruiting nowThe purpose of this study is to evaluate the diagnostic performance of 18F-FDG micro-PET-CT in malignant Head and neck cancer compared to definitive histological analysis (gold standard).
Sponsor: Centre Henri Becquerel • Aim: Diagnosis
Last updated Jun 27, 2026 08:04 UTC
-
New drug GT801 tested for tough autoimmune cases
Disease control Recruiting nowThis is a single-arm, open-label, dose-escalation and dose-expansion clinical trial designed to evaluate the safety, efficacy, and cellular metabolism kinetics of GT801 in the treatment of moderate-to-severe refractory autoimmune diseases. Interim analysis will be conducted when …
Early phase 1 • Sponsor: Grit Biotechnology • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New drug TR-002 enters human testing for Hard-to-Treat cancers
Disease control Recruiting nowThis phase I trial tests the safety, side effects and best dose of TR-002 for the treatment of solid tumors that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced), that cannot be removed by surgery (unresectable), t…
Phase 1 • Sponsor: University of California, Davis • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Pharmacy letters could boost vaccination and cut stroke risk
Prevention OngoingThe goal of this individual-level pragmatic randomized policy trial is to learn about the impact of behavioural nudges via mailed letters on increasing influenza and travel vaccination uptake in Alberta, Canada. The primary outcome is the proportion of adults receiving influenza …
Sponsor: University of Calgary • Aim: Prevention
Last updated Jun 27, 2026 09:03 UTC